Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial	CNS demyelinating autoimmune disease, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, nervous system disorder, neuralgia, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, peripheral nervous system disorder	Not yet recruiting	Phase 4	2026-07-13		NCT07699770

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tang-Du Hospital	93

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tiantan Hospital, Capital Medical University	Beijing	China	9
Inner Mongolia People's Hospital	Hohhot	China	3
Tangdu Hospotal	Xi'an	China	2
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	38
The First Affiliated Hospital of Harbin Medical University	Harbin	China	17
The First Affiliated Hospital of Kunming Medical University	Kunming	China	17
The First Hospital of China Medical University	Shenyang	China	42
The First Hospital of Jilin University	Changchun	China	3
the First Hospital of Tsinghua University	Beijing	China	1
Xinjiang Uygur Autonomous Region People's Hospital	Ürümqi	China	1